COVID-19: AstraZeneca and University of Oxford’s Vaccine Candidate Shows Promise in Early Human Trials
By Ruchi Jhonsa, Ph.D. The experimental coronavirus vaccine developed by the University of Oxford, together with pharmaceutical giant AstraZeneca was able to generate strong T cell and antibody immune response …
Read More